Healthcare

Malaria Treatment Market Competitive Landscape 2024-2033

Overview and Scope

Malaria treatment refers to the medical interventions and procedures used to diagnose, manage, and cure malaria, which is a potentially life-threatening mosquito-borne disease caused by the Plasmodium parasite.

Sizing and Forecast

The malaria treatment market size has grown strongly in recent years. It will grow from $1.49 billion in 2023 to $1.57 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to discovery of effective drugs, vector control efforts, global health initiatives, scientific research, health infrastructure development.

The malaria treatment market size is expected to see strong growth in the next few years. It will grow to $1.94 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to drug resistance monitoring, climate change impact, precision medicine and genomic approaches, healthcare financing reforms, integration of digital health solutions. Major trends in the forecast period include epidemiological surveillance enhancement, alternative medicine integration, malaria vaccines development, data-driven treatment programs, education and training programs.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/malaria-treatment-global-market-report

Segmentation & Regional Insights

The malaria treatment market covered in this report is segmented –

1) By Treatment: Prescription Medications, Vaccines, Diagnostic Tests, Other Treatments
2) By Route of Administration: Oral, Parenteral, Intravenous
3) By Distribution Channel: Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
4) By End User: Hospitals, Specialty Clinics, Homecare, Other End Users

Middle East and Africa was the largest region in the malaria treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the malaria treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11939&type=smp

Major Driver Impacting Market Growth

The high incidence of malaria is expected to propel the growth of the malaria treatment market going forward. Malaria refers to a potentially life-threatening mosquito-borne disease caused by the Plasmodium parasite, characterized by recurring fever and other flu-like symptoms. This shift has resulted from poverty, limited access to healthcare services, climate change, lack of malaria control measures, and drug resistance. Malaria treatment helps to effectively manage and cure the infection caused by the Plasmodium parasite. For instance, in November 2023, according to World Malaria Report by World Health Organization, a Switzerland-based international public health organization, in 2021, 247 million cases of malaria were reported as compared to 245 million cases in 2020. Therefore, the high incidence of malaria is driving the growth of the malaria treatment market.

Key Industry Players

Major companies operating in the malaria treatment market report are Pfizer Inc., Merck & Co., Johnson & Johnson, Roche Holding AG, Bayer AG, Novartis AG, Sanofi SA, AstraZeneca Plc, GlaxoSmithKline PLC., Takeda Pharmaceutical Company Limited, Sumitomo Chemical Co. Ltd., Viatris Inc., Mylan N.V., Sandoz International GmbH, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Serum Institute of India, Cipla Ltd., Amneal Pharmaceuticals LLC, Lupin Ltd., Zydus Lifesciences Limited, Ipca Laboratories Ltd., Chongqing Holley Pharmaceutical Co. Ltd., Zydus Lifesciences Ltd., Medicines Sans Frontières (Doctors Without Borders), Strides Pharma Science Limited, Swiss Tropical and Public Health Institute (Swiss TPH), Aprecia Pharmaceuticals LLC, AdvaCare Pharma USA LLC, Medicines for Malaria Venture (MMV), VLP Therapeutics LLC, Actiza Pharmaceutical Private Limited

The malaria treatment market report table of contents includes:

1. Executive Summary

2. Malaria Treatment Market Characteristics

3. Malaria Treatment Market Trends And Strategies

4. Malaria Treatment Market – Macro Economic Scenario

5. Global Malaria Treatment Market Size and Growth

32. Global Malaria Treatment Market Competitive Benchmarking

33. Global Malaria Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Malaria Treatment Market

35. Malaria Treatment Market Future Outlook and Potential Analysis

36. Appendix

Email: info@tbrc.info